Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
"Letter urging CMS to rescind 42 C.F.R. § 433.400 and return to its
original interpretation of FFCRA Section 6008."
Letter to HHS offering additional comments regarding specific aspects of the 1557 proposed rule.
Comments in response to the ACA Section 1557 proposed rule with a focus on scope of proposed nondiscrimination regulations, proposed discrimination through benefit design, proposed discrimination through excessive utilization management, discrimination of copay accumulator adjustment programs. potential discrimination of value assessments, and need for enforcement.
Letter urging President Biden to direct the Office of Management and Budget (OMB) to release the proposed rule for a Special Registration to Engage in the Practice of Telemedicine.
Letter to the Senate to follow the House by acting to pass a two-year extension of important telehealth policies, while continuing to push for a permanent extension, that includes provisions to lift provider and patient location limitations, remove in-person requirements for telemental health, ensure continued access to clinically appropriate controlled substances without in-person requirements, and increase access to telehealth services in the commercial market.
Letter commending House Committee on Ways and Means for passing legislation out of committee that will make it easier for people to access critical mental health and substance use disorder services.
Letter to urge Congress to use the Prescription Drug User Fee Act (PDUFA) reauthorization to enact reforms to strengthen the Accelerated Approval drug review pathway (a critical regulatory tool which has yielded life-saving therapies).
Support of the passage of S. 4449 / H.R. 8188, the Saving Access to Laboratory Services Act (SALSA) which would update Medicare’s payment system for laboratory services, ensuring our laboratory infrastructure is equipped to support the full range of testing that patients need every day and in times of public health crisis, and fostering innovation in future diagnostics.
Letter urging TennCare (Tennessee's state Medicaid program) to reinstate retroactive coverage for all Medicaid eligibility groups in the state.
Letter in support of the Inflation Reduction Act including enhanced Advanced Premium Tax Credits while addressing that more could have been done to address the Medicaid coverage gap in the non-expansion states.